Global Pharmaceutical Hot Melt Extrusion Equipment Market Report 2020-2027 Featuring Baker Perkins, Coperion, Leistritz, Milacron, Thermo Fisher Scientific & Xtrutech - ResearchAndMarkets.com

The "Pharmaceutical Hot Melt Extrusion Equipment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Pharmaceutical Hot Melt Extrusion Equipment estimated at US$29.9 Million in the year 2020, is projected to reach a revised size of US$38.9 Million by 2027, growing at a CAGR of 3.9% over the analysis period 2020-2027.

Twin Screw Extruders, one of the segments analyzed in the report, is projected to record a 3.6% CAGR and reach US$24.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Single Screw Extruder segment is readjusted to a revised 4% CAGR for the next 7-year period.

The U. S. Market is Estimated at $8.1 Million, While China is Forecast to Grow at 6.2% CAGR

The Pharmaceutical Hot Melt Extrusion Equipment market in the U. S. is estimated at US$8.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$7.8 Million by the year 2027 trailing a CAGR of 6.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Laboratory Extruder Segment to Record 5.1% CAGR

In the global Laboratory Extruder segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Million in the year 2020 will reach a projected size of US$1.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.1 Million by the year 2027, while Latin America will expand at a 5.5% CAGR through the analysis period.

The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Baker Perkins Ltd.
• Coperion GmbH
• Leistritz AG
• Milacron Holdings Corp.
• Thermo Fisher Scientific, Inc.
• Xtrutech Ltd.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Global Competitor Market Shares
• Pharmaceutical Hot Melt Extrusion Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

• Market Facts & Figures
• US Pharmaceutical Hot Melt Extrusion Market Share (in %) by Company: 2019 & 2025
• Market Analytics

CANADA

JAPAN

CHINA

EUROPE

• Market Facts & Figures
• European Pharmaceutical Hot Melt Extrusion Market: Competitor Market Share Scenario (in %) for 2019 & 2025
• Market Analytics

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

• Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/o5kmmx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201005005737/en/